News From the 2016 American Society of Hematology (ASH) Meeting

 

Patient Power was on-site at the 2016 American Society of Hematology (ASH) meeting in San Diego to bring you the latest blood cancer-related treatment and research news.

What Are We Learning From Genetic Testing in MPNs?

At ASH 2016, experts from across the nation discuss how genetic testing is affecting the evolution of treatment for MPNs.

Published:

A Review of Current and Developing Therapies for MPNs

MPN experts from around the nation came together at ASH 2016 to review current and developing therapies for MPNs.

Published:

A Doctor, Patient and Care Partner: Understanding Cancer From All Angles With Jim Omel

Get perspective on multiple myeloma with James (Jim) Omel: doctor, patient, patient advocate, and care partner all rolled into one.

Published:

Torben Plesner: It's a Great Time to Be a Myeloma Doctor

Dig deeper into multiple myeloma research progress with international myeloma expert, Dr. Torben Plesner.

Published:

David’s MPN Story: Why I Choose to Stay Positive

David Denny, a Baptist pastor from Canton, Ohio, shares his story with Patient Power about his 2013 diagnosis with primary myelofibrosis and discusses what he does to stay positive throughout his journey with the illness.

Published:

Partner Spotlight: Updates From the MPN Research Foundation at ASH 2016

At ASH 2016, Patient Power caught up with Michelle Woehrle from the MPN Research Foundation to learn more about a new patient registry system called myMPN.

Published:

Next-Generation Sequencing for Myeloma: What Does This Mean for Patients?

At the 2016 American Society of Hematology (ASH) meeting, Dr. Brian Walker of the UAMS Myeloma Institute joined Patient Power to discuss the importance of researching genes and mutations to learn more about myeloma.

Published:

Myeloma News From ASH 2016: An Update From Dr. Rafael Fonseca

Mayo Clinic’s Dr. Rafael Fonseca provides updates on myeloma news out of ASH 2016.

Published:

ASH 2016: Hodgkin Lymphoma News

What is the ASH 2016 news for Hodgkin lymphoma patients? Expert Dr. John Burke explains.

Published:

ASH 2016: Lymphoma Research News Update

Get educated on the latest lymphoma news out of ASH 2016 with Dr. John Burke of Rocky Mountain Cancer Centers.

Published:

Evolving CML Research: Assessing the Need for Ongoing Treatment in Clinical Trials

Is there such thing as treatment-free remission for a CML patient? Dr. Jessica Altman of Robert H. Lurie Comprehensive Cancer Center of Northwestern University shares news from ASH 2016.

Published:

MPN News From ASH 2016: An Update From Dr. Claire Harrison

Hear what the latest MPN news from ASH 2016 means for patients with Dr. Claire Harrison of Guy and St. Thomas’ Hospital.

Published:

MPN News From ASH 2016: An Update From Dr. Srdan Verstovsek

Dr. Srdan Verstovsek of MD Anderson Cancer Center shares a comprehensive overview of the MPN treatments being discussed at ASH 2016.

Published:

Jack Aiello: ASH16 Unexpected Treatment Jewels in Myeloma

Achieve a better quality of life with your multiple myeloma. 22-year myeloma survivor, Jack Aiello, shares his perspective on ASH 2016.

Published:

Interferon Therapy for MPNs: An Update From ASH 2016

Is interferon or hydroxyurea more effective as a PV treatment? MPN expert and researcher, Dr. Heinz Gisslinger, discusses the results from PROUD-PV Phase III study.

Published:

Updates in CML From ASH 2016: Reducing Therapy Safely

Learn how CML patients are safely reducing TKI therapy through a clinical trial in the UK. Researcher from the University of Glasgow, Dr. Mhairi Copland, reports.

Published:

ASH 2016 Roundtable: Is Precision Immunotherapy the Future for Myeloma Patients?

Get all the myeloma updates from ASH 2016 with Dr. Robert Orlowski and a panel of experts and advocates.

Published:

ASH 2016: Cutaneous T-Cell Lymphoma Treatment News

Learn about new and emerging cutaneous T-cell lymphoma news out from ASH2016, explained by Dr. Steven Horwitz of Memorial Sloan Kettering Cancer Center.

Published:

MPN News From ASH 2016: Reviving the Role of Interferon Treatment

As part of our 2016 ASH coverage, Dr. John Mascarenhas joined Patient Power to discuss the research taking place with interferon as a treatment for MPNs.

Published:

ASH 2016 Expert Roundtable: What Does Emerging CLL Research Mean for Patients?

At the 2016 American Society of Hematology (ASH) meeting, Andrew Schorr leads an expert panel as they discuss CLL news from the conference.

Published:

ASH 2016: MPN News and Updates From an Expert Panel

As part of our coverage from the 2016 American Society of Hematology (ASH) annual meeting, MPN experts Dr. Catriona Jamieson, Dr. John Mascarenhas, Dr. Stephen Oh and our own Andrew Schorr, gathered to discuss the latest updates on treatment and research.

Published:

ASH Daily News: Monday, December 5

Patient Power hosts Andrew Schorr and Mary Windishar share their reflections about the conference on-site at the last day of ASH 2016.

Published:

ASH Daily News: Sunday, December 4

Patient Power hosts Andrew Schorr and Mary Windishar share a daily news summary on-site at day two of ASH 2016.

Published:

ASH Daily News: Saturday, December 3

Patient Power hosts Andrew Schorr and Mary Windishar share a daily news summary on-site at ASH 2016.

Published:


Page last updated on February 15, 2017